Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish

D M Langenau1, M D Keefe, N Y Storer

  • 1Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 2115, USA. dlangenau@enders.tch.harvard.edu

Oncogene
|March 18, 2008
PubMed

Insights

This study introduces a novel co-injection method in zebrafish, enabling mosaic transgenesis for cancer research. This approach effectively identifies gene pathways crucial for tumor initiation and radiation sensitivity.

Area of Science:

  • Genetics
  • Cancer Biology
  • Zebrafish Models

Background:

  • Zebrafish are valuable genetic cancer models.
  • Stable transgenic methods have limitations for disease induction.

Purpose of the Study:

  • To develop a new strategy for cancer modeling in zebrafish.
  • To identify gene pathways in tumor initiation and radiation sensitivity.

Main Methods:

  • A co-injection strategy for microinjecting zebrafish embryos.
  • Utilizing mosaic transgenesis for synergistic gene effects.
  • Analyzing gene pathways involved in tumor formation.

Main Results:

  • Successfully implemented a co-injection strategy for zebrafish.
  • Identified gene pathways critical for tumor initiation.
  • Discovered gene pathways influencing radiation sensitivity.

Conclusions:

  • Mosaic transgenesis in zebrafish offers a powerful tool for cancer research.
  • This method enhances the study of tumor development and treatment response.

Related Concept Videos